Effect of Placebo on Meal-stimulated Gastric Acid Secretion and Serum Gastrin Concentration. Studies in Healthy Volunteers and Duodenal Ulcer Patients

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 1988 Feb 1

PMID 3338362

Authors

M Feldman

C T Richardson

Affiliations

Soon will be listed here.

Abstract

The effect of placebos on gastric acid secretion in humans is unknown, even though placebo therapy is relatively effective in ulcer patients. Therefore, we evaluated the effect of a placebo capsule on meal-stimulated gastric acid secretion and serum gastrin concentrations in 10 healthy subjects and also in 10 patients with chronic duodenal ulcer. Each subject and patient was studied twice and in random order, once with placebo therapy prior to the meal and once without placebo. In either healthy subjects or duodenal ulcer patients, meal-stimulated acid secretion and serum gastrin concentrations were not significantly different with or without placebo administration. These studies demonstrate that a placebo capsule, administered by a physician just prior to a meal, has little, if any, effect on acid secretion or gastrin release in response to the meal. Any beneficial effects of placebos in treating patients with peptic ulcer disease are probably unrelated to inhibition of meal-stimulated gastric acid secretion.

References

Feldman M, Richardson C, PETERSON W, Walsh J, Fordtran J . Effect of low-dose propantheline on food-stimulated gastric acid secretion: comparison with an "optimal effective dose" and interaction with cimetidine. N Engl J Med. 1977; 297(26):1427-30. DOI: 10.1056/NEJM197712292972603. View

Sonnenberg A, Muller-Lissner S, Vogel E, Schmid P, Gonvers J, Peter P . Predictors of duodenal ulcer healing and relapse. Gastroenterology. 1981; 81(6):1061-7. View

SARLES H, CAMATTE R, Sahel J . A study of the variations in the response regarding duodenal ulcer when treated with placebo by different investigators. Digestion. 1977; 16(4):289-92. DOI: 10.1159/000198080. View

Schiller L, Fordtran J . Ulcer complications during short-term therapy of duodenal ulcer with active agents and placebo. Gastroenterology. 1986; 90(2):478-81. DOI: 10.1016/0016-5085(86)90950-9. View

Scheurer U, Witzel L, Halter F, Keller H, Huber R, Galeazzi R . Gastric and duodenal ulcer healing under placebo treatment. Gastroenterology. 1977; 72(5 Pt 1):838-41. View

Binder H, Cocco A, Crossley R, FINKELSTEIN W, Font R, Friedman G . Cimetidine in the treatment of duodenal ulcer: a multicenter double blind study. Gastroenterology. 1978; 74(2 Pt 2):380-8. View

Richardson C, Walsh J, Cooper K, Feldman M, Fordtran J . Studies on the role of cephalic-vagal stimulation in the acid secretory response to eating in normal human subjects. J Clin Invest. 1977; 60(2):435-41. PMC: 372385. DOI: 10.1172/JCI108793. View

Blair 3rd A, Feldman M, Barnett C, Walsh J, Richardson C . Detailed comparison of basal and food-stimulated gastric acid secretion rates and serum gastrin concentrations in duodenal ulcer patients and normal subjects. J Clin Invest. 1987; 79(2):582-7. PMC: 424132. DOI: 10.1172/JCI112850. View

Sturdevant R, Isenberg J, Secrist D, ANSFIELD J . Antacid and placebo produced similar pain relief in duodenal ulcer patients. Gastroenterology. 1977; 72(1):1-5. View

10.

Isenberg J, PETERSON W, Elashoff J, Sandersfeld M, Reedy T, Ippoliti A . Healing of benign gastric ulcer with low-dose antacid or cimetidine. A double-blind, randomized, placebo-controlled trial. N Engl J Med. 1983; 308(22):1319-24. DOI: 10.1056/NEJM198306023082203. View

11.

Eysselein V, Maxwell V, REEDY T, Wunsch E, Walsh J . Similar acid stimulatory potencies of synthetic human big and little gastrins in man. J Clin Invest. 1984; 73(5):1284-90. PMC: 425149. DOI: 10.1172/JCI111330. View

12.

Fordtran J . Placebos, antacids and cimetidine for duodenal ulcer. N Engl J Med. 1978; 298(19):1081-3. DOI: 10.1056/NEJM197805112981911. View